Cancer News and Research

Latest Cancer News and Research

Oxygen levels induce X chromosome inactivation in female cells: Study

Oxygen levels in the lab can permanently alter human embryonic stem (ES) cells, specifically inducing X chromosome inactivation in female cells, according to Whitehead Institute researchers. Human ES cells have been routinely created and maintained at atmospheric levels of oxygen, which is about 20%. Cells in the body are usually exposed to only 1-9% oxygen.

14 May 2010

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

BioSante Pharmaceuticals, Inc. today reported on its recent developments and financial results for the first quarter, and its cash balance as of March 31, 2010.

14 May 2010

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.

14 May 2010

American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the first quarter of 2010.

14 May 2010

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.

14 May 2010

New initiative to reduce health inequities

A major new initiative by the University of Maryland aims to eliminate health disparities in the state and extend the impact of health reform. The university's School of Public Health has recruited a team of nationally recognized faculty-researchers who will create action programs to improve primary care and expand public health outreach, so as to reduce the high rates of chronic disease in Maryland's medically underserved communities.

14 May 2010

ATCC unveils new brand identity

ATCC, the premier biomaterials resource and standards organization, today proudly unveiled its new brand initiative. The fresh identity is a bold and confident logotype featuring the brand promise—THE ESSENTIALS OF LIFE SCIENCE RESEARCH. GLOBALLY DELIVERED.™ The new brand promise is an accurate reflection of ATCC's multiple offerings and global distribution network. Launch of the rebrand will bring focus to ATCC's extended capabilities as a reagents and tools company in support of life science research.

14 May 2010

Medtronic releases Virtual ICD study data

Medtronic, Inc. released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients would be free of inappropriate shocks one year after implant and 92 percent at five years post-implant.

14 May 2010

Study examines impact of tobacco smoke carcinogen on mice

Although tobacco use is widely understood to be one of the leading causes of oral cancer, research on the prevention of tobacco-related oral cancer in experimental animals has traditionally been limited to examining the impact of synthetic carcinogens manufactured especially for cancer research, rather than on observing the effects of carcinogens that occur in tobacco smoke.

14 May 2010

Researchers determine how cells regulate chromosome/microtubule interface

Whitehead Institute researchers have determined a key part of how cells regulate the chromosome/microtubule interface, which is central to proper chromosomal distribution during cell division.

14 May 2010

RMEI, PIM sponsor continuing education series on castration-resistant prostate cancer

Castration-resistant prostate cancer (CRPC), defined as tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Current treatment regimens are complicated by toxicities and a low rate of relapse-free survival. Many novel therapies in clinical trials offer hope for patients with this challenging diagnosis. Healthcare professionals who are treating CRPC must stay abreast of these emerging therapies to ensure optimal care for these patients.

14 May 2010

New research to improve treatment for oesophageal and upper stomach cancer

Poor diet, too much alcohol, smoking and increasing obesity could be leading to an epidemic of oesophageal and upper stomach cancer, according to a leading UK team of specialists at The University of Nottingham and Nottingham University Hospitals.

14 May 2010

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

New data from a multi-centric international registry study show that cellular-level imaging with Mauna Kea Technologies' Cellvizio®, the world's smallest microscope, appears to significantly improve a physician's ability to diagnose or rule out early forms of bile duct cancer during a standard endoscopic diagnostic exam.

14 May 2010

Study shows correlation between good mental health and academic performance in children

Children's social-emotional competencies are directly related to how well they do in math and reading according to the results of a study presented at the annual meeting of the American Educational Research Association in Denver, Colorado.

14 May 2010

Medical professionals meet to standardize CT scanning techniques

A national summit of medical professionals meeting last month in Atlanta called for the creation of consensus scan techniques as a way of addressing the concerns of patients undergoing CT scans -- a common medical imaging procedure that uses X-rays to show cross-sectional images of the body.

14 May 2010

Each melanoma cell capable of cancer stem cell behavior: Study

Scientists at The Wistar Institute offer a new explanation for the persistent ability of melanoma cells to self-renew, one of the reasons why melanoma remains the deadliest form of skin cancer. The concept of the "dynamic stemness" of melanoma can explain why melanoma cells behave like both conventional tumor cells and cancer stem cells.

14 May 2010

Inhibitex reports net loss of $4.8M for first-quarter 2010

Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.

14 May 2010

ISCA recommends chromosomal microarray as new standard for genetic evaluation of children

An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray (CMA) as the new standard practice for genetic evaluation of children with unexplained developmental delay, autism or birth defects.

14 May 2010

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

NiTi™ Surgical Solutions, an innovative surgical device company, today provided an update of sales and clinical data highlights related to its lead product ColonRing™, the first major advance in reconnection technology for gastrointestinal surgery in more than 30 years.

14 May 2010

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

14 May 2010

Cancer News and Research

Latest Cancer News and Research

Oxygen levels induce X chromosome inactivation in female cells: Study

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

American Shared Hospital Services first-quarter revenue decreases 2% to $4,088,000

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

New initiative to reduce health inequities

ATCC unveils new brand identity

Medtronic releases Virtual ICD study data

Study examines impact of tobacco smoke carcinogen on mice

Researchers determine how cells regulate chromosome/microtubule interface

RMEI, PIM sponsor continuing education series on castration-resistant prostate cancer

New research to improve treatment for oesophageal and upper stomach cancer

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

Study shows correlation between good mental health and academic performance in children

Medical professionals meet to standardize CT scanning techniques

Each melanoma cell capable of cancer stem cell behavior: Study

Inhibitex reports net loss of $4.8M for first-quarter 2010

ISCA recommends chromosomal microarray as new standard for genetic evaluation of children

NiTi Surgical Solutions completes over 4,000 successful ColonRing applications in 16 countries

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in